Glucotrack Announces Its Implantable Glucose Monitor Has Completed 30 Days Of A 60-Day Preclinical Study
Glucotrack Announces Its Implantable Glucose Monitor Has Completed 30 Days Of A 60-Day Preclinical Study
Glucotrack宣佈其植入式血糖監測儀已完成爲期30天的60天臨床前研究
Glucotrack Announces Its Implantable Glucose Monitor Has Completed 30 Days Of A 60-Day Preclinical Study
Glucotrack宣佈其植入式血糖監測儀已完成爲期30天的60天臨床前研究
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。